IBER NYSE
Ibere Pharmaceuticals
1W: +0.1%
1M: +0.3%
3M: +2.2%
1Y: +5.6%
$10.18
Last traded 2023-03-01 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$175.6M
52W Range9.75-10.75
Volume44,499
Avg Volume85,046
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
2005 Market Street
Philadelphia, PA 19103
US
Philadelphia, PA 19103
US
267 765 3222
About Ibere Pharmaceuticals
Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Vollmer Louis J. | P-Purchase | 10,000 | $10.00 | 2021-03-02 |
| Kerekes Zoltan | 3,350,000 | — | 2021-02-25 | |
| PIPV Capital LLC | 3,350,000 | — | 2021-02-25 | |
| IMASOGIE OSAGIE O | 3,350,000 | — | 2021-02-25 | |
| Vollmer Louis J. | 25,000 | — | 2021-02-25 |